WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  7.675

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased from  5.464 to 7.675 for Year 2026.

  • WJAHR: MARCH ISSUE PUBLISHED

    MARCH 2026 Issue has been successfully launched on MARCH 2026.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR March 2026 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

CERVICOVAGINAL PLACENTAL ALPHA MICROGLOBULIN-1 FOR THE PREDICTION OF PRETERM BIRTH IN WOMEN WITH SUSPECTED PRETERM BIRTH

Duaa Mustaf Radhwan*, Najah Shaker Yassen

ABSTRACT

Background: Preterm birth is one of the most challenging and critical issues in obstetrics. Despite decades of study and therapeutic progress, roughly 10% of neonates are born prematurely. Early prediction of preterm labor allows for timely intervention (e.g. drug administration, neonatal intensive care unit preparation). One potential marker is placental Alpha microglubolin-1. It is a specific α-1 globulin secreted by decidual cells and amniotic epithelial cells early in pregnancy. It is associated with physiological changes occurring in the cervix and fetal membranes during labor and is predominantly found in high concentrations in amniotic fluid. Aim of study: To evaluate the role of cervicovaginal placental alpha microglobulin-1 for the prediction of the timing of spontaneous preterm birth. Patients and methods: This is an analytic cohort study that included 90 pregnant women presented with a suspicion of preterm labor and was conducted at the Gynecology and Obstetrics department of Baghdad Teaching Hospital/ Medical City, Baghdad. The study duration was from 1st of February 2024 to the end of November 2024. Inclusion criteria involved singleton pregnancy with intact membrane and cervical dilatation of ≤3 cm of gestational age (28 – 36 weeks + 6 days). Patients were categorized into four groups according to the time of delivery: Group I (preterm delivery within one week), group II (preterm delivery within two weeks), and group III (delivery after two weeks). All patients were test for placental alpha microglobulin-1 at time of admission. Results: Statistical analysis revealed that cervical placental alpha macroglobulin – 1 was a significant predictor of preterm delivery within 1 week, and 2 weeks. For predicting spontaneous preterm labor within 7 days, the optimal cut-off point was determined to be 6.46 ng/ml, resulting in a sensitivity of 98.6%, specificity of 88.9%, positive predictive value of 97.2%, and negative predictive value of 94.1%. Finally, the optimal threshold for predicting preterm labor within 14 days was established at 5.54 ng/ml, demonstrating a sensitivity of 96.2%, specificity of 100%, positive predictive value of 100.0%, and negative predictive value of 78.57%. Conclusion: Cervical placental alpha macroglobulin - 1 was shown to be a reliable predictor of the timing of spontaneous preterm birth in women suspected of preterm labor. Notably, it showed highest sensitivity and specificity within 1 week; and thus, effectively risk stratifying women who would be at risk of spontaneous preterm delivery within one week of symptom onset.

[Full Text Article] [Download Certificate]